Cite
Obeticholic Acid Prevents Fibrosis in a Model of Tubulointerstitial Kidney Disease.
MLA
Davidson, Shania R., et al. “Obeticholic Acid Prevents Fibrosis in a Model of Tubulointerstitial Kidney Disease.” FASEB Journal, vol. 36, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1096/fasebj.2022.36.S1.R3613.
APA
Davidson, S. R., Adapa, S., Lopez, S. I., Dial, K., Rowland, E., Mykala, K., Wang, X., Rosenberg, A., Levi, M., & Jones, B. A. (2022). Obeticholic Acid Prevents Fibrosis in a Model of Tubulointerstitial Kidney Disease. FASEB Journal, 36, N.PAG. https://doi.org/10.1096/fasebj.2022.36.S1.R3613
Chicago
Davidson, Shania R., Sharmila Adapa, Santiago, Isabel Lopez, Katelyn Dial, Emma Rowland, Komuraiah Mykala, Xiaoxin Wang, Avi Rosenberg, Moshe Levi, and Bryce A. Jones. 2022. “Obeticholic Acid Prevents Fibrosis in a Model of Tubulointerstitial Kidney Disease.” FASEB Journal 36 (May): N.PAG. doi:10.1096/fasebj.2022.36.S1.R3613.